[The treatment of states of failure due to cerebral atrophy with beta-pyridyl-carbinol (Ronicol)].
D000368:Aged; D000425:Alcohol Amnestic Disorder / Q000188:drug therapy; D001284:Atrophy / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D001927:Brain Diseases / Q000188:drug therapy*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000188:drug therapy; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D007263:Infusions, Parenteral; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D011725:Pyridines; D014665:Vasodilator Agents; D005947:Glucose; D007099:Imipramine
Die Behandlung hirnatrophisch begründeter Versagenszustände mit Infusionen von Beta-Pyridyl-Carbinol (Ronicol)